A carregar...
Immune Checkpoint Inhibitors in Advanced-Stage Non-small Cell Lung Cancer
More than half of non-small cell lung cancer (NSCLC) patients are at an advanced stage at the time of diagnosis, and they have a poor prognosis. Systemic treatment is the basic treatment approach for advanced-stage NSCLC, and chemotherapy and targeted treatments are commonly used based on the molecu...
Na minha lista:
| Publicado no: | Turk Thorac J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish Thoracic Society
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783068/ https://ncbi.nlm.nih.gov/pubmed/29404172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2017.17006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|